Pennsylvania State Senator diagnosed with follicular NHL

Pennsylvania State Senator Mike Folmer (R-Lebanon) has announced that he has been diagnosed with lymphoma.

Specifically, Sen. Folmer has been diagnosed with follicular non-Hodgkin's lymphoma, a not-uncommon diagnosis for his age group, and the most commonly diagnosed NHL subtype.

His statement:

“In the spirit of the openness and transparency I often talk so much about, I want to share with my constituents and colleagues that I have been diagnosed with non-Hodgkin lymphoma. My specific type is follicular grade I, the most common type of non-Hodgkin lymphoma, and highly treatable. I join more than a half of million other Americans living with the disease, and look forward to joining the many others who have been successfully treated, including Microsoft co-founder Paul Allen, hockey great Mario Lemieux, and former United States Senator Arlen Specter.

“Those who know me best are aware of my strong faith and the importance of family, and as my doctors chart a course of treatment, I will rely on my faith and support of family and friends. As Jeremiah 29:11 reads: ‘For I know the plans I have for you,’ says the Lord. ‘They are plans for good and not for disaster, to give you a future and a hope.’

“As I begin and continue with treatments, I plan to attend to Senate business as normal and remain as committed to representing the citizens of the 48th district as I have been since taking office. I also give my word to my constituents I will periodically update them on my condition through various forms of media and my weekly e-newsletter, Mike’s Memo.”

It should be noted that the personalities noted by the Senator were all diagnosed and treated for Hodgkin's lymphoma, not follicular non-Hodgkin's lymphoma (although Allen was later diagnosed with NHL as well).

Source: WHP TV

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap